Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pediatrics ; 122(3): e670-4, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18678601

RESUMO

BACKGROUND: Patients with autoimmune thyroiditis can present with thyroid function that varies from euthyroidism to frank hypothyroidism or occasionally hyperthyroidism. Although there is a risk of progression from the euthyroid or subclinical hypothyroid state to frank hypothyroidism, the rate of progression is not known. OBJECTIVES: Subjects with diffuse goiter and autoimmune thyroiditis were followed up to observe the rate of deterioration in thyroid function from euthyroid and subclinical hypothyroid states to hypothyroidism. METHODS: Patients who presented with goiter and autoimmune thyroiditis were grouped as those with euthyroidism, subclinical hypothyroidism, and overt hypothyroidism on the basis of levels of thyroxine and thyrotropin at presentation. Patients were followed up for a minimum duration of 24 months with periodic monitoring of thyroid function. RESULTS: Ninety-eight consecutive subjects (aged of 8-18 years) with a diagnosis of autoimmune thyroiditis and diffuse goiter were studied. At presentation, in 24 subjects (24.5%) thyroid function was normal (euthyroidism), 32 (32.6%) had subclinical hypothyroidism, and the remaining 42 subjects (42.9%) had hypothyroidism. All of the subjects with hypothyroid were maintained euthyroid on thyroxine during follow-up. Hypothyroidism developed in 3 of 24 patients with euthyroidism and in 4 of 32 patients with subclinical hypothyroidism. CONCLUSIONS: Subjects with goitrous autoimmune thyroiditis need periodic monitoring of thyroid function. Development of thyroid dysfunction is insidious and may not be accompanied by symptoms and clinical signs. In pediatric and adolescent age groups it is imperative to correct thyroid dysfunction to achieve optimal growth and development.


Assuntos
Autoanticorpos/imunologia , Bócio/epidemiologia , Tireoidite Autoimune/epidemiologia , Adolescente , Biópsia por Agulha Fina , Criança , Progressão da Doença , Feminino , Seguimentos , Bócio/diagnóstico , Bócio/etiologia , Humanos , Incidência , Índia/epidemiologia , Masculino , Prognóstico , Radioimunoensaio , Fatores de Risco , Tireoglobulina , Glândula Tireoide/imunologia , Glândula Tireoide/metabolismo , Glândula Tireoide/patologia , Tireoidite Autoimune/complicações , Tireoidite Autoimune/diagnóstico , Tiroxina/sangue , Fatores de Tempo
2.
J Pediatr Endocrinol Metab ; 19(7): 889-93, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16995568

RESUMO

Delhi lies in the sub-Himalayan plains and the existence of iodine deficiency is well established. Iodised salt was introduced in Delhi nearly two decades ago. The aim of the present study was to determine the status of iodine nutrition in school-aged children and the prevalence of autoimmune thyroiditis. A total of 4,320 schoolchildren (2,218 [51.3%] boys) aged 10-16 years were studied. Goitre was detected in 396 children, an overall goitre prevalence of 9.2%. Of the 396 children with goitre, 112 (28.3%) had evidence of autoimmune thyroiditis (AIT). The median urinary iodine (UI) excretion in the study population as a whole was 14.6 microg/dl. The median UI in the group of children with goiter was 13.3 microg/dl, whereas UI in children with goiter and evidence of AIT was 16.6 microg/dl (p <0.01). Of the 112 children with AIT, 77 (68.7%) were euthyroid, 23 (20.5%) had subclinical hypothyroidism, eight (7.2%) had hypothyroidism and the remaining four (3.6%) had hyperthyroidism. UI was high in goitrous children with AIT, and in children with thyroid dysfunction. Further studies are needed to clarify whether the higher UI in goitrous children with AIT is causally related to AIT or is due to the inability of the diseased thyroid to trap available iodine efficiently.


Assuntos
Fenômenos Fisiológicos da Nutrição Infantil , Bócio/epidemiologia , Iodo/administração & dosagem , Cloreto de Sódio na Dieta/administração & dosagem , Tireoidite Autoimune/epidemiologia , Adolescente , Criança , Feminino , Humanos , Índia/epidemiologia , Iodo/deficiência , Iodo/uso terapêutico , Masculino , Estado Nutricional , Prevalência , Instituições Acadêmicas , Estudantes
3.
Surg Today ; 33(8): 571-6, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12884093

RESUMO

PURPOSE: We conducted this study to establish whether human thyroid tissue autografts can survive and function in the absence of their native blood supply in muscle. The benefits of this potential could be incorporated in routine surgery to reduce the incidence of post-operative hypothyroidism. METHODS: Fifteen patients with benign thyroid disorders, seven of whom had Graves' disease and eight, multinodular goiter (MNG), underwent modified subtotal thyroidectomy and the autotransplantation of thyroid tissue in the sternocleidomastoid muscle. About 3-5 g of thyroid tissue was cut and implanted into the sternocleidomastoid muscle. Postoperative clinical assessment, thyroid function tests, and technetium scans of the neck were done to assess the function of remnant and transplanted thyroid tissue. RESULTS: The transplanted tissue was functional in six of the eight patients with MNG and four of the seven with Graves' disease. All the patients with MNG and a functional transplant became euthyroid within 6 months postoperatively. Although the transplanted tissue was functional in four patients with Graves' disease, only one became euthyroid, while the other three required supplemental hormone therapy for postoperative hypothyroidism. CONCLUSIONS: These findings demonstrate the ability of autotransplanted thyroid tissue to survive, function, and grow in muscle.


Assuntos
Sobrevivência de Enxerto , Glândula Tireoide/transplante , Seguimentos , Bócio Nodular/cirurgia , Doença de Graves/cirurgia , Humanos , Músculos do Pescoço/cirurgia , Cintilografia , Pertecnetato Tc 99m de Sódio , Testes de Função Tireóidea , Glândula Tireoide/diagnóstico por imagem , Glândula Tireoide/fisiologia , Tireoidectomia/métodos , Fatores de Tempo , Transplante Autólogo
4.
Thyroid ; 12(7): 591-8, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12193303

RESUMO

BACKGROUND: Infantile hypothyroidism, either caused by iodine-deficiency disorder (IDD) or congenital hypothyroidism (CH), is the world's leading cause of preventable mental retardation. Such hypothyroidism has virtually been eliminated in the developed world by salt iodization and neonatal thyroid screening. However, most developing countries do not have neonatal thyroid screening programs. Using India as an example, we review the case for newborn screening in the developing world. METHODS: A literature review on infantile hypothyroidism in India was conducted and three Indian thyroid experts were queried about their views on neonatal screening in India. RESULTS: Iodine nutrition improved markedly in India during the 1990s; 49% of the households are now using adequately iodized salt. The control of IDD is still insufficient in India. Nationally representative data on neonatal screening in India are not available, but two regional studies have been published. One study (n = 12,407) measured cord blood thyrotropin and the other (n = 25,244) measured filter paper thyroxine. These studies reported difficult socioeconomic and organizational barriers to the implementation of neonatal screening in India. DISCUSSION: It is time for India to make neonatal thyroid screening and mandatory iodization of salt a priority and develop a comprehensive infantile hypothyroidism policy. Prioritization of infantile hypothyroidism prevention is justified by its high frequency, sensitivity of screening in detecting both IDD and CH, adverse consequences of missing diagnosis at birth, high effectiveness of prevention, severity of disability from hypothyroidism, cost effectiveness of prevention, and lack of a clinical method of diagnosis near birth.


Assuntos
Hipotireoidismo Congênito , Países em Desenvolvimento , Hipotireoidismo/diagnóstico , Recém-Nascido/sangue , Programas de Rastreamento , Tireotropina/sangue , Humanos , Hipotireoidismo/sangue , Índia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA